ConcertAI Clinical Trial Solutions (PrecisionTrials™)
by ConcertAI
· Based in United States →
— Leader in Generative & Agentic AI Solutions Accelerating Life Sciences & Healthcare
Contact for pricing
Regulatory Status Disclosed
Overview
ConcertAI Clinical Trial Solutions (PrecisionTrials™) is an AI-powered platform designed to optimize various aspects of clinical trials, primarily in oncology. It is intended for use by clinical leaders at sponsors and Contract Research Organizations (CROs), as well as research and medical teams involved in clinical development.
- What it does: The platform leverages real-world data and AI to streamline the clinical trial lifecycle, from study design and site selection to patient recruitment and risk monitoring. It aims to accelerate trial timelines and reduce operational complexities.
- How it fits a clinical or practice workflow: ConcertAI Clinical Trial Solutions integrates AI-driven insights directly into clinical workflows. For instance, its TriaLinQ module, part of the CancerLinQ Suite, automates patient-to-trial matching by identifying eligible patients faster than traditional manual methods. The PatientLinQ module, embedded within the EHR, provides oncologists with real-time, data-driven insights and cohort comparisons to support treatment decisions.
- Notable capabilities:
- AI-driven study design and validation: The platform utilizes AI to help design and refine patient cohorts, predict study outcomes, and reduce trial amendments.
- Optimized site selection and patient recruitment: It recommends high-performing sites and aims to boost patient recruitment through AI-powered site selection, real-time data, and predictive insights.
- Real-world data integration: It uses ConcertAI’s Precision360 dataset, which includes over 13 million de-identified patient records across various cancer types, refreshed weekly.
- Workflow automation: The platform employs agentic AI to automate critical trial activities such as literature reviews, protocol design, feasibility assessments, and patient matching.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Optimize clinical trial design
- AI-powered site selection
- Enhanced patient recruitment
- Leverages real-world data (RWD)
- Utilizes generative AI
- Provides actionable insights for clinical teams
- Accelerates and de-risks clinical trials
- Improves study timelines
- Patient Matching & Automation
- Deep, broad, multi-modal oncology RWD
Use Cases
- Clinical trial design optimization
- Identifying optimal clinical trial sites
- Streamlining patient recruitment
- Accelerating clinical development
- Generating real-world evidence for trials
- Improving trial timelines and efficiency
What Physicians Need to Know
Molecule Screening Capability
Not a primary feature of ConcertAI Clinical Trial Solutions (PrecisionTrialsu2122), which focuses on clinical trial optimization rather than early-stage drug discovery.
Clinical Trial Matching
Leverages AI-powered trial screening and patient-to-trial matching using real-world data (RWD) and genomic insights to identify eligible patients and refine inclusion/exclusion criteria. It supports site workflows for efficient patient matching to complex trial enrollment criteria.
Real-World Evidence Analysis
A core strength, utilizing near real-time oncology RWD to define and refine patient cohorts, optimize protocols, and model study outcomes. The broader Precision Suite includes 'Precision Explorer' for rapid generation of outcomes analysis, treatment pathways, and cohort comparisons using generative AI.
Genomic Data Integration
Strongly emphasized through Precision360u2122, which integrates EMR and genomic data with claims and social determinants of health. Collaborations with entities like Foundation Medicine and Guardant Health combine extensive clinical data with genomic insights, including whole-slide imaging and tumor profiling, to accelerate precision oncology.
Literature Mining
The underlying CARAai platform and the 'Accelerated Clinical Trials (ACT)' solution support automated literature reviews. Precision Explorer also features an integrated literature search that provides citation-backed context for results.
Target Identification
While not a direct feature of PrecisionTrialsu2122 itself, the Precision360u2122 data environment is designed for life sciences discovery, supporting hypothesis advancement and disease burden modeling, which can indirectly contribute to target identification.
Safety Signal Detection
Not explicitly highlighted as a direct feature of PrecisionTrialsu2122. The platform's primary focus is on optimizing trial design, patient recruitment, and operational efficiency.
Collaboration Features
Precision Explorer enables sharing of analyses, cohorts, reports, and personalized boards for efficient team collaboration. The Precision Suite is designed for enterprise-wide value and supports multi-party collaborations, including strategic partnerships with leading biomedical innovators and healthcare providers.
Publication Support
Precision Explorer can generate evidence suitable for peer-reviewed publications or regulatory submissions, offering citation-backed insights. ConcertAI also maintains a robust publication record, showcasing its research output.
Physician Tip
Physicians can leverage ConcertAI's PrecisionTrialsu2122 to enhance patient care by more precisely identifying eligible patients for clinical trials, thereby expanding access to novel therapies. The platform's use of real-world and genomic data helps ensure trial protocols align with actual clinical practice, potentially reducing screen failures and improving patient outcomes. The insights gained from RWE analysis can also inform treatment decisions and disease management strategies.
The Precision Suite, including PrecisionTrialsu2122, is API-enabled and built to support flexible integration with existing data environments and enterprise tools. It integrates with sources like PubMed and ClinicalTrials.gov, and connects with common trial platforms to fit into current workflows. The CARAai platform also supports connectors to various data sources, including EMRs and genomic data from partners like Foundation Medicine and Guardant Health.
Details
| Category | Drug Discovery & Research |
| Pricing | Contact for pricing — Custom pricing based on scope, features, and enterprise requirements. |
| Deployment | SaaS |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | No AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology |
What the Web Says
ConcertAI Clinical Trial Solutions (PrecisionTrialsu2122) leverages AI, particularly agentic AI, and real-world data to streamline and accelerate oncology clinical trials. The platform aims to improve various aspects of trials, from design and site selection to patient recruitment and data management, ultimately reducing timelines and costs. It has been noted for its ability to significantly speed up patient screening compared to traditional methods.
Overall: PositiveStrengths
- Accelerated patient screening (up to 3x faster than traditional methods).
- Reduced clinical trial timelines (potential to shorten by 10-20 months).
- Decreased costly protocol amendments (by approximately 50%).
- Improved site selection and activation timelines (by 25-50%).
- Enhanced patient matching and recruitment, including addressing diversity and enrollment goals.
- Integration of real-world data (RWD) and AI for more proactive and data-driven trial design.
Limitations
- Limited public reviews from physicians, healthcare IT, and tech reviewers on platforms like G2 and Capterra.
- Focus primarily on oncology, with specific tumor types currently supported (Breast, Colorectal, NSCLC), though more are coming.
- Reliance on proprietary AI models and data, which may raise questions about transparency and independent validation for some users.
- Potential for a learning curve associated with new AI-powered workflows.
- No specific negative feedback or limitations were found in the provided search results from independent sources.
Based on reviews from: ConcertAI, HIT Consultant, Elion Health, PR Newswire, HLTH, TechTarget, Business Wire, Reddit, G2, Capterra, Fierce Biotech
Last updated: 2026-07-26
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ConcertAI Clinical Trial Solutions (PrecisionTrials™)
Press & Coverage
Physician Ai Tools
ConcertAI Clinical Trial Solutions (PrecisionTrialsu2122)
ConcertAI's PrecisionTrialsu2122 is an AI SaaS solution designed for drug discovery and research, adhering to regulations like HIPAA and security standards like SOC 2 Type II and GDPR.
unknown
Physician Ai Tools
Drug Discovery & Research Archives
This archive features articles related to drug discovery and research, including information on ConcertAI Clinical Trial Solutions (PrecisionTrialsu2122).
unknown
Videos
Product demos, reviews, and walkthroughs for ConcertAI Clinical Trial Solutions (PrecisionTrials™).
Loading videos...
Frequently Asked Questions
PrecisionTrialsu2122 leverages real-world data and generative AI to help physicians design and refine patient cohorts, optimize inclusion/exclusion criteria, and recommend study design improvements for oncology clinical trials. It also aids in predicting study outcomes and selecting high-performing sites, ultimately aiming to accelerate drug discovery and development.
ConcertAI's PrecisionTrialsu2122 is built with compliance in mind, utilizing HIPAA-compliant and de-identified real-world data through expert determination. The platform's consulting and analytic services also deliver regulatory-grade real-world evidence suitable for submissions, ensuring data integrity and adherence to standards.
Currently, PrecisionTrialsu2122 primarily focuses on oncology, supporting specific tumor types like Breast, Colorectal, and NSCLC, though more are being added. Physicians might also face broader challenges in precision medicine implementation, such as reimbursement issues for advanced testing or variations in care provider pathways, which can impact trial execution.
Yes, several companies offer similar solutions for clinical trial optimization and real-world data analysis. Notable alternatives include TriNetX, Tempus, Flatiron Health, Castor EDC, and Inspirata, each with their own strengths in areas like data management, AI-driven insights, or specific therapeutic focuses.
While specific pricing models are not publicly detailed, PrecisionTrialsu2122 is offered as a SaaS solution. Its value proposition emphasizes significant cost savings by reducing unplanned study amendments by up to 50%, eliminating months of delays, and improving enrollment performance, which can translate into millions in operational savings for Phase II and III studies.
Suggest an Edit →
| Last Verified: 2026-04-24 | First Added: 2026-04-24